M1 Kliniken AG
XETRA:M12

Watchlist Manager
M1 Kliniken AG Logo
M1 Kliniken AG
XETRA:M12
Watchlist
Price: 14.4 EUR 1.41%
Updated: Aug 14, 2024
Have any thoughts about
M1 Kliniken AG?
Write Note
Section:
 

Wall Street
Price Targets

M12 Price Targets Summary
M1 Kliniken AG

Wall Street analysts forecast M12 stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for M12 is 27.2 EUR with a low forecast of 25.25 EUR and a high forecast of 29.4 EUR.

M12 Lowest Forecast
Wall Street Target
25.25 EUR
75% Upside
M12 Average Forecast
Wall Street Target
27.2 EUR
89% Upside
M12 Highest Forecast
Wall Street Target
29.4 EUR
104% Upside
Lowest
Price Target
25.25 EUR
75% Upside
Average
Price Target
27.2 EUR
89% Upside
Highest
Price Target
29.4 EUR
104% Upside
M1 Kliniken AG Competitors:
Price Targets
ASTERDM
Aster DM Healthcare Ltd
9% Upside
BH
Bumrungrad Hospital PCL
20% Upside
C
085660
Chabiotech Co Ltd
28% Upside
2120
Wenzhou Kangning Hospital Co Ltd
93% Upside
ASTERDM
Aster DM Healthcare Ltd
9% Upside
BH
Bumrungrad Hospital PCL
20% Upside
C
085660
Chabiotech Co Ltd
28% Upside
2120
Wenzhou Kangning Hospital Co Ltd
93% Upside
RDOR3
Rede D'Or Sao Luiz SA
29% Upside
SGRY
Surgery Partners Inc
37% Upside
G
3689
Guangdong Kanghua Healthcare Co Ltd
401% Upside
R
RJH
Rajthanee Hospital PCL
17% Upside

Revenue
Forecast

Revenue Estimate
M1 Kliniken AG

For the last 8 years the compound annual growth rate for M1 Kliniken AG's revenue is 32%. The projected CAGR for the next 3 years is 8%.

32%
Past Growth
8%
Estimated Growth
Estimates Accuracy
-5%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
M1 Kliniken AG

For the last 8 years the compound annual growth rate for M1 Kliniken AG's operating income is 9%. The projected CAGR for the next 3 years is 33%.

9%
Past Growth
33%
Estimated Growth
Estimates Accuracy
-8%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
M1 Kliniken AG

For the last 8 years the compound annual growth rate for M1 Kliniken AG's net income is 6%. The projected CAGR for the next 3 years is 28%.

6%
Past Growth
28%
Estimated Growth
Estimates Accuracy
6%
Average Beat
What are analyst estimates?

See Also

Summary
M12 intrinsic value, competitors valuation, and company profile.
DCF Valuation
M12 stock valuation using Discount Cash Flow valuation method.
Relative Valuation
M12 stock valuation using valuation multiples.
Wall Street Estimates
M12 price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
M12 stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is M12's stock price target?
Price Target
27.2 EUR

According to Wall Street analysts, the average 1-year price target for M12 is 27.2 EUR with a low forecast of 25.25 EUR and a high forecast of 29.4 EUR.

What is M1 Kliniken AG's Revenue forecast?
Projected CAGR
8%

For the last 8 years the compound annual growth rate for M1 Kliniken AG's revenue is 32%. The projected CAGR for the next 3 years is 8%.

What is M1 Kliniken AG's Operating Income forecast?
Projected CAGR
33%

For the last 8 years the compound annual growth rate for M1 Kliniken AG's operating income is 9%. The projected CAGR for the next 3 years is 33%.

What is M1 Kliniken AG's Net Income forecast?
Projected CAGR
28%

For the last 8 years the compound annual growth rate for M1 Kliniken AG's net income is 6%. The projected CAGR for the next 3 years is 28%.

Back to Top
ALPHA SPREAD
Join more than 166,700+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.